Skip to main content
Signal8

Oncology Pharma Inc. (ONPH)

Oncology Pharma Inc. is a pharmaceutical firm specializing in oncology, dedicated to the development, manufacturing, and commercialization of therapeutic agents. The company has a collaborative and licensing agreement with Kalos Therapeutics Inc. to explore treatment possibilities for the COVID-19 virus. Originally incorporated in 1993, the company was known as SourcingLink.net Inc. until it rebranded as Oncology Pharma Inc. in June 2019. Its operations are based in San Francisco, California.

Sector: Shell Companies

Industry: Shell Companies

Oncology Pharma Inc. logo

Oncology Pharma Inc.

OTC:ONPHHealthcare
+12.50%$0.0405
CLOSED
Mkt Cap$3.33M
EV-
Float15.22M
O/S82.16M
VOL3K sh
$ Vol$115
RVOL0.19×
Inst Own-
SI0.1%
Net Cash/Sh-
Dilution
Oncology Pharma Inc. logoOTC:ONPHClosed$0.0405+12.50%
FormDescription
    Oncology Pharma Inc. (ONPH) SEC Filings: 10-K, 10-Q, 8-K | Signal8